USE OF NITROGEN-CONTAINING COMPLEXING AGENTS FOR DEODORIZATION AND ANTIMICROBIAL TREATMENT OF THE SKIN AND TEXTILE FIBRE MATERIALS

Abstract

The present invention relates to the use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and of textile fibre materials.

Description

[0001] The present invention relates to the use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of the skin and of textile fibre materials.

[0002] It is known that various nitrogen-containing complexing agents, for example ethylene-diaminetetraacetic acid (EDTA), nitrilotriacetic acid (NTA), &bgr;-alaninediacetic acid (EDETA) or ethylenediaminedisuccinic acid (EDDS) are widely employed in domestic detergents because of their complexing properties.

[0003] Surprisingly, it has been found that certain nitrogen-containing complexing agents also have an antimicrobial action against Gram-positive bacteria and are therefore particularly suitable for deodorization and antimicrobial treatment of the human skin and of textile fibre materials.

[0004] The present invention therefore relates to the use of nitrogen-containing complexing agents for antimicrobial treatment of the skin and of textile fibre materials.

[0005] Compounds which are preferably used according to the invention as complexing agents are those of the formula 3

[0006] in which

[0007] Q1, is Carb1; Carb2,; or a radical of the formula —(CH2)m1—OH

[0008] Q2 is hydrogen or Carb2; and

[0009] Q3 is Carb3; an amino acid radical; or a radical of the formula (1a) 4

[0010] where Carb1, Carb2 and Carb3 independently of one another are the radical of a C1-C8-mono- or dicarboxylic acid; and

[0011] m1 is 1 to 5.

[0012] Compounds which are particularly preferred here are those of the formula (1) in which the amino acid radical Q3 has the formula 5

[0013] and especially compounds of the formula (1) in which

[0014] Q1 is a monocarboxylic acid; or a radical of the formula —(CH2)m1—OH;

[0015] Q2 is hydrogen or a monocarboxylic acid; and

[0016] Q3 is formula (1b); or a monocarboxylic acid.

[0017] Complexing agents which are of particular interest are those of the formula (1) in which Carb2 and Carb3, independently of one another are the radical of the formula

—[(CH2)]n1—COOH,  (1c)

[0018] in which

[0019] n1 is 0 to 5.

[0020] Complexing agents which are important in practice have the formula 6

[0021] or the formula 7

[0022] Nitrilotriacetic acid (NTA) is furthermore suitable as the complexing agent.

[0023] Other examples of complexing agents which can be employed according to the invention are aminotrimethylenephosphoric acid (ATMP) of the formula 8

[0024] serinediacetic acid (SDA) of the formula 9

[0025] asparaginediacetic acid of the formula 10

[0026] methylglycinediacetic acid (MGDA) of the formula (7) 11

[0027] The nitrogen-containing complexing agents employed according to the invention can be employed not only as the acid but also in the form of the water-soluble salts, preferably as lithium, sodium, potassium, ammonium and ethanolammonium salts.

[0028] Ethylenediaminedisuccinic acid (EDDS) of the formula (2) has two asymmetric carbon atoms. Various stereoisomeric forms of this compound are therefore possible. The (S,S) configuration of EDDS has the formula 12

[0029] An inexpensive chemical synthesis leads to a mixture of the three forms S,S; R,R; and meso-EDDS. However, separation of these stereoisomeric compounds requires a high industrial expenditure. Optically pure (S,S)-EDDS can be prepared with the aid of an Actinomycetes strain (T. Nishikiori et al., Production by Actinomycetes of (S,S)-N,N′-ethylenediaminedisuccinic acid, an inhibitor of phospholipase c; J.Antibiotics 37, 426-427 (1984)).

[0030] The purely chemical preparation of the compound of the formula (9) is carried out in a manner known per se, such as is described, for example, by J. A. Neal, N. Rose in Inorganic Chemistry,7, 2405 (1985).

[0031] Racemic EDDS can be prepared in accordance with U.S. Pat. No. 3,158,635.

[0032] The complexing agents according to the invention show a pronounced bacteriostatic action, in particular against Gram-positive bacteria of the skin flora, for example Corynebacterium xerosis (bacteria which causes body odour). They are therefore particularly suitable as the antimicrobial active substance in body care compositions, for example soaps, shampoos, foot care products and, in particular, deodorants, as well as an additive in detergents.

[0033] The invention therefore also relates to a body care composition comprising at least one nitrogen-containing complexing agent and carriers or auxiliaries which are tolerated in comsetics.

[0034] The body care composition according to the invention comprises 0.01 to 15, preferably 0.5 to 10, % by weight, based on the total weight of the composition, of a nitrogen-containing complexing agent and auxiliaries which are tolerated in cosmetics.

[0035] Depending on the form in which the body care composition is present, it also comprises, in addition to the complexing agent, other constituents, for example sequestering agents, dyes, perfume oils, thickeners or consolidating agents (consistency regulators), emmollients, UV absorbers, skin protection agents, antioxidants, additives which improve the mechanical properties, such as dicarboxylic acids and/or Al, Zn, Ca, or Mg salts of C14-C22 fatty acids, and, if appropriate, preservatives.

[0036] Because of their good water-solubility, the complexing agents according to the invention can be incorporated into the corresponding formulations without problems.

[0037] The body care compositions according to the invention can be formulated as a water-in-oil or oil-in-water emulsion, as alcoholic or alcohol containing formulation, as a vesicular dispersion of an ionic or nonionic amphiphilic lipid, as a gel or solid stick or as an aerosol formulation.

[0038] As a water-in-oil or oil-in-water emulsion, the auxiliary which is tolerated in cosmetics preferably comprises 5 to 50% of an oily phase, 5 to 20% of an emulsifier and 30 to 90% of water. The oily phase can comprise any oil suitable for cosmetic formulations, for example one or more hydrocarbon oils, a wax, a naturally occurring oil, a silicone oil, a fatty acid ester or a fatty alcohol. Preferred mono- or polyols are ethanol, isopropanol, propylene glycol, hexylene glycol, glycerol and sorbitol.

[0039] An anitmicrobial soap has, for example, the following composition:

[0040] 0.01 to 5% by weight of the compound of the formula (2)

[0041] 0.3 to 1% by weight of titanium dioxide

[0042] 1 to 10% by weight of stearic acid

[0043] to 100% of soap base, for example the sodium slats of tallow fatty and coconut fatty acid or glycerols.

[0044] A shampoo has, for example, the following composition:

[0045] 0.01 to 5% by weight of the compound of the formula (2),

[0046] 12.0% by weight of sodium laureth-2-sulfate,

[0047] 4.0% by weight of cocamidopropylbetaine,

[0048] 3.0% by weight of NaCl and

[0049] water to 100%.

[0050] A deodorant has, for example, the following composition:

[0051] 0.01 to 5% by weight of the compound of the formula (2),

[0052] 60% by weight of ethanol,

[0053] 0.3% by weight of perfume oil and

[0054] water to 100%.

[0055] The complexing agents according to the invention are furthermore suitable for the treatment of textile fibre materials. The fibre materials are non-dyed and dyed or printed fibre materials, for example of silk, leather, wool, polyamide or polyurethanes, and in particular all types of cellulosic fibre materials. Such fibre materials are, for example, naturally occurring cellulosic fibres, such as cotton, linen, jute and hemp, and cellulose and regenerated cellulose. Textile fibre materials which are preferably suitable are those of cotton.

[0056] The following examples serve to illustrate the invention.

EXAMPLE 1

[0057] Determination of the Antimicrobial Activities of S,S-EDDS, R,R-EDDS, Racemate of EDDS and EDETA, EDTA and NTA

[0058] Test method: An agar diffusion test is carried out with the following modifications:

[0059] Medium: casein-soya flour peptone agar (caso-agar)

[0060] Test organisms: Corynebacterium xerosis ATCC 373

[0061] Corynebacterium xerosis ATCC 7711

[0062] Corynebacterium minutissimum ATCC 23358

[0063] Procedure: 500 ml of caso-agar are innoculated with 3.5 ml of an overnight culture of the bacteria, diluted 1:100, and caso plates (18 ml) are covered with a layer of about 5 ml of the bacteria-containing agar. After the plates have cooled, holes of diameter 1 cm are stamped out with a cork borer. Each stamped-out hole is filled with in each case 100 &mgr;l of a test substance dilution and the plates are incubated at 37° C. for 2 days. Double-distilled water is employed as the solvent for all the substances. In the case of EDETA GS, the pH is adjusted to 3.3 by addition of 1 N NaOH. Chemically prepared S,S-EDDS is adjusted to the pH of 5.6 by addition of 1 N NaOH.

[0064] Controls: Double-distilled water

[0065] The test results are listed in Table 1: 1 TABLE 1 Concen- Inhibitory aureola diameter tration Cory. xerosis Cory. xerosis Substance [ppm] AUG 7711 ATTC 373 EDETA 10000 5/51 1/11 S,S-EDDS 10000 15/151 10/101 (prepared chemically) S,S-EDDS 10000 15/151 10/101 (prepared by fermentation EDTA 10000 2/2  5/5  R,S-EDDS 10000 n.d. 12/13  R,R-EDDS 10000 n.d. 15/15  1Slight growth on inhibitory aureolas

[0066] The test results show that both EDETA, EDTA and the EDDS prepared by fermentation and chemically (═R,R; S,S; R,S) show a pronounced bacteriostatic action against Corynebacterium xerosis.

[0067] Examples of formulations having a bacteriostatic action

EXAMPLE 2

[0068] Preparation of a Washing Powder 2 Laurylammonium sulfate 8.0% Nonionic surfactants 2.9% Soaps 3.5% Sodium tripolyphosphate 43.8%  Sodium silicate 7.5% Magnesium silicate 1.9% Carboxymethylcellulose 1.2% EDTA 0.2% Sodium sulfate 21.2%  EDDS 1% Water to 100%

[0069] The formulation is prepared as follows:

[0070] The solid components are mixed and homogenized in a mortar and stirred with deionized water until a uniform pourable and pumpable paste (slurry) is obtained, which is finally spray-dried.

EXAMPLE 3

[0071] Preparation of a Cleansing Tonic 3 Ethanol 20%  Glycerol 5% PEG-40 hydrogenated castor oil 1% (hydrogenated ethoxylated castor oil) EDDS   0.5% Perfume ad libidum Water to 100%

[0072] The formulation is prepared as follows:

[0073] EDDS is dissolved in ethanol. Under stirring at room temperature PEG-40, glycerol and perfume are added. Finally, the water is added.

EXAMPLE 3

[0074] Preparation of a Deodorant Stick 4 Ethanol 20% Glycerol 30% Propylene glycol 20% Ceteareth-25  3% (= ethoxylated cetyl/stearyl alcohol) Sodium stearate  7% EDDS 0,5%  Perfume ad libidum Water to 100%

[0075] The formulation is prepared as follows:

[0076] Sodium stearate is melted at 60° C. Propylene glycol, Cetearath-25 and glycerol are added to the melting until a homogeneous clear suspension is obtained. Finally, the suspension is stirred with a EDDS-solution in an alcohol/water mixture at 50° C. and cooled slowly.

EXAMPLE 4

[0077] Preparation of Soluble EDDS Salts and Deodorant Formulations

[0078] S,S-EDDS is obtained by means of microbiological (WO 96/36725) or chemical synthesis (J. A. Neal et al., Inorg.Chem. 7, 2405 (1968)). Racemic EDDS is prepared from maleic anhydride and ethylenediamine (U.S. Pat. No. 3,158,635).

[0079] A 1% suspension of racemic EDDS or S,S-EDDS is prepared in water/ethanol (about 7:3) with vigorous stirring. An aqueous solution of NaOH is metered in with an autoamtic titration device until the pH of 7 remains constant for 30 minutes. Any slight milky clouding which occurs is removed by filtering through paper.

[0080] By addition of a thickener like hydroxy ethyl cellulose a clear deodorant formulation which is stable at room temperature, comprises about 1% of active substance (based on the tetra-acid) and has a skin-friendly pH is obtained.

[0081] If NaOH is replaced by KOH, ammonia or ethanolamine, the corresponding potassium, ammonium and ethanolammonium salts are obtained. Lithium hydroxide, sodium carbonate, sodium bicarbonate or laurylamine can also be employed as the base.

EXAMPLE 5

[0082] Detection of the Substantial Antimicrobial Activity of R,S-EDDS Salts on the Skin 5 Formulations 1% of R,S-EDDS/sodium salt (Solutions in 30% ethanol): 1% of R,S-EDDS/amine salt (for the preparation, cf. Example 4) Medium: Casein-soya flour peptone agar (caso-agar) Test organism: Corynebacterium xerosis ATCC 373

[0083] Test method:

[0084] Before application of the test solutions, the underarms are washed with a non-antimicrobial soap twice for 1 minute each time. A total of 6 ml of test product is then applied to the washed, dry skin of the underarm. Immediately and 2 hours after application of the test products, the EDDS on the skin is extracted by means of discs of filter paper (2 cm diameter) moistened in 0.9% NaCl solution (pH: 8.2). For this, the moist filter disc is placed on the treated skin without airbubbles for 4 minutes. The filter discs are subsequently dried at room temperature and then placed on solid agar media with test bacteria.

[0085] To prepare the solid agar media, 500 ml of liquid agar are innoculated with 3.5 ml of a 12-16-hour culture, diluted 1:100, of the test bacteria at 47° C. and caso plates (18 ml) are covered with a layer of about 5 ml of the bacteria-containing agar.

[0086] After the filter discs have been placed on top, the agar media are incubated for 2 days at 37° C. and the inhibition under the filter disc or the inhibitory aureolas of the filter discs is/are then determined.

[0087] The test results are listed in Table 2: 6 TABLE 2 Substance Inhibitory aureola dia- meter (mm)/inhibition under the filter disc* Coryneb. xerosis ATCC 373 Placebo 0/0 R,S-EDDS (sodium salt) immed- 5/4 iately 2 hours 3/4 after application R,S-EDDS (Amine salt) immed- 2,5/4   iately 2 hours 2/4 after application *Inhibition under the filter disc:

[0088] Explanation:

[0089] 0=good growth (no inhibition)

[0090] 2=inhibited but clear growth (weak inhibition)

[0091] 4=no growth (potent inhibition)

[0092] The test results show that a pronounced inhibition of Corynebacterium xerosis is achieved with both test substances.

[0093] The test shows that sufficiently high concentrations of EDDS to achieve inhibition of Corynebacterium xerosis are also still present on the skin 2 hours after the last application.

Claims

1. The use of a nitrogen-containing complexing agent for antimicrobial treatment of the skin and of textile fibre materials.

2. The use according to claim 1, wherein a compound of the formula

13

in which

Q1, is Carb1; Carb2,; or a radical of the formula —(CH2)m1—OH;

Q2 is hydrogen or Carb2; and

Q3 is Carb3; an amino acid radical; or a radical of the formula (1a)

14

where Carb1, Carb2 and Carb3 independently of one another are the radical of a C1-C8-mono- or dicarboxylic acid; and

m1 is 1 to 5, is used as the complexing agent.

3. The use as claimed in claim 1 or 2, wherein the amino acid radical Q3 has the formula

15

4. The use according to claim 3, wherein

Q1 is a monocarboxylic acid; or a radical of the formula —(CH2)m1—OH;

Q2 is hydrogen or a monocarboxylic acid; and

Q3 is formula (ib); or a monocarboxylic acid.

5. The use according to claim 1 or 2, wherein Carb2 and Carb3, independently of one another are the radical of the formula

—[(CH2)]n1—COOH,  (1c)

in which

n1 is 0 to 5.

6. The use according to any one of claims 1 to 4, wherein the compound of the formula

16

is employed as the complexing agent.

7. The use according to any one of claims 1 to 4, wherein the compound of the formula

17

is employed as the complexing agent.

8. The use according to claim 1, wherein nitrilotriacetic acid is used as the complexing agent.

9. The use of a complexing agent according to any one of claims 1 to 8, wherein the complexing agent is also in the form of one of its water-soluble salts.

10. The use according to claim 9, wherein the complexing agent is present in the form of its lithium, sodium, potassium, ammonium or ethanolammonium salt.

11. The use of a complexing agent according to any one of claims 1 to 10 as an antimicrobial active substance against Gram-positive bacteria.

12. The use of a complexing agent according to any one of claims 1 to 11 in body care compositions.

13. A body care composition comprising a nitrogen-containing complexing agent according to claim 1.

14. A body care composition according to claim 13 in the form of a soap, a shampoo or a deodorant.

15. The use of a complexing agent according to any one of claims 1 to 10 in textile fibre materials.